Loading...
Resonance Health Limited
RHT.AX•ASX
Healthcare
Medical - Healthcare Information Services
A$0.04
A$0.00(0.00%)
Resonance Health Limited (RHT.AX) Financial Performance & Income Statement Overview
Review Resonance Health Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
95.02%
↑ 95.02%
Operating Income Growth
137.28%
↑ 137.28%
Net Income Growth
121.70%
↑ 121.70%
Operating Cash Flow Growth
983.44%
↑ 983.44%
Operating Margin
1.67%
↑ 1.67%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-2.94%
↓ 2.94%
ROE
-2.95%
↓ 2.95%
ROIC
1.34%
↑ 1.34%
Resonance Health Limited (RHT.AX) Income Statement & Financial Overview
Review Resonance Health Limited's (RHT.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $5.32M | $3.27M | $2.30M | $2.10M |
| Cost of Revenue | $0.00 | $0.00 | -$67000.00 | $0.00 |
| Gross Profit | $5.32M | $3.27M | $2.37M | $2.10M |
| Gross Profit Ratio | $1.00 | $1.00 | $1.03 | $1.00 |
| R&D Expenses | $170260.00 | $531476.00 | $310685.00 | $397566.00 |
| SG&A Expenses | $4.38M | $3.20M | $2.53M | $2.35M |
| Operating Expenses | $4.55M | $3.74M | $2.84M | $2.75M |
| Total Costs & Expenses | $4.55M | $3.98M | $3.05M | $2.98M |
| Interest Income | $73851.00 | $63983.00 | $26735.00 | $13164.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $67439.00 | $242693.00 | $204895.00 | $231464.00 |
| EBITDA | $58725.00 | -$314858.00 | -$378664.00 | -$449039.00 |
| EBITDA Ratio | $0.01 | -$0.14 | -$0.23 | -$0.31 |
| Operating Income | $774847.00 | -$712470.00 | -$743370.00 | -$881480.00 |
| Operating Income Ratio | $0.15 | -$0.22 | -$0.32 | -$0.42 |
| Other Income/Expenses (Net) | -$844184.00 | -$376659.00 | -$252377.00 | -$186190.00 |
| Income Before Tax | -$69337.00 | -$557552.00 | -$583556.00 | -$680500.00 |
| Income Before Tax Ratio | -$0.01 | -$0.17 | -$0.25 | -$0.32 |
| Income Tax Expense | -$796192.00 | -$3.00 | -$54988.00 | -$428707.00 |
| Net Income | $726855.00 | -$557552.00 | -$528568.00 | -$251793.00 |
| Net Income Ratio | $0.14 | -$0.17 | -$0.23 | -$0.12 |
| EPS | $0.002 | -$0.001 | -$0.001 | -$0.001 |
| Diluted EPS | $0.002 | -$0.001 | -$0.001 | -$0.001 |
| Weighted Avg Shares Outstanding | $460.91M | $464.63M | $461.15M | $461.15M |
| Weighted Avg Shares Outstanding (Diluted) | $465.52M | $464.63M | $461.15M | $461.15M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan